SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.85-4.5%Jan 9 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (6418)5/23/2002 4:17:50 PM
From: Biomaven  Read Replies (2) of 52153
 
Yes, 8-2 in favor of approval. We can all heave a sigh of relief for the biotech sector here, although FDA approval is not guaranteed. (The non-biotech people are of course confusing the AC panel with the FDA - this doesn't at all mean that the FDA has suddenly become easier).

I guess my prediction from a while back turned out correct:

I think that the AC will vote to approve Amevive, but that there will be some dissension.

Message 17452333

However I didn't put my money where my mouth was - I ended up sitting this one out altogether. So on that basis I decline to take any credit for the prediction. <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News